12:00 AM
 | 
Aug 20, 2012
 |  BC Week In Review  |  Company News  |  Deals

Affitech, Roche deal

Affitech received an undisclosed milestone payment from Roche under a May 2007 deal granting Roche rights to LC06, a human anti- angiopoietin 2 ( ANG2; ANGPT2) antibody....

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >